Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells-Reference-Cited by-同舟云学术

Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells

Published:2013-08 Issue:15 Volume:12 Page:2409-2422
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Pincini Alessandra,Tornillo Giusy,Orso Francesca,Sciortino Marianna,Bisaro Brigitte,Leal Maria del Pilar Camacho,Lembo Antonio,Brizzi Maria Felice,Turco Emilia,De Pittà Cristiano,Provero Paolo,Medico Enzo,Defilippi Paola,Taverna Daniela,Cabodi Sara

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.25415

Reference64 articles.

1. Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World

2. Breast cancer: origins and evolution

3. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

4. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S100 proteins in mammary gland regulation and their role in breast cancer metastasis;Advances in Cancer Biology - Metastasis;2023-10

2. Prognostic and tumor-immune infiltration cell signatures in tamoxifen-resistant breast cancers;Gland Surgery;2021-09

3. Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion;British Journal of Cancer;2020-11-04

4. Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in Resistance;DNA and Cell Biology;2019-02

5. Inositol-1,4,5-trisphosphate 3-kinase-A (ITPKA) is frequently over-expressed and functions as an oncogene in several tumor types;Biochemical Pharmacology;2017-08